CD55 upregulation in T cells of COVID-19 patients suppresses type-I interferon responses
Open Access
- 2 May 2025
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-14
Abstract
Complement overactivation, has been verified in COVID-19 patients. Complement regulatory proteins, including CD55, control complement overactivation thus eliminating complement deposition and cell lysis. We investigated complement regulatory protein expression in COVID-19 for potential deregulated expression patterns driving disease pathogenesis. Single-cell RNA-seq revealed increased PBMCs CD55 expression in severely and critically ill patients. This increase was also detected upon integrated subclustering analysis of monocyte, T cell and B cell populations. FACS analysis confirmed the significant upregulation of CD55 expression in CD4+ and CD8+ T cells and monocyte populations of severely and critically ill COVID-19 patients. This upregulation was associated with decreased expression of type-I IFN-stimulated genes (ISGs) in patients with severe and critical COVID-19, indicating a suppressor effect of CD55. Silencing of CD55 in T cells from COVID-19 severely ill patients in vitro and sensitization with SARS-CoV-2 peptides resulted in significantly augmented expression of ISGs and a reversal of their expression to levels similar to control or higher. The present study uncovers, to the best of our knowledge, a novel regulatory effect of CD55 on type-I IFN responses of severely ill COVID-19 patients, thus indicating its contribution to COVID-19 pathogenesis, and identifies a novel mechanistic pathway in the COVID-19 immune response.Keywords
This publication has 43 references indexed in Scilit:
- COVID-19 pandemic waves: Identification and interpretation of global dataHeliyon, 2024
- Complement and complement regulatory proteins are upregulated in lungs of COVID-19 patientsPathology - Research and Practice, 2023
- UCell: Robust and scalable single-cell gene signature scoringComputational and Structural Biotechnology Journal, 2021
- Type I IFN immunoprofiling in COVID-19 patientsJournal of Allergy and Clinical Immunology, 2020
- Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic DataCell Systems, 2019
- Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infectionsHuman Immunology, 2013
- Complement regulators and inhibitory proteinsNature Reviews Immunology, 2009
- Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell–induced inflammationNature Immunology, 2002
- Decay acceleration of the complement alternative pathway C3 convertaseImmunopharmacology, 1999
- Structure and Function of the Complement Receptors, CR1 (CD35) and CR2 (CD21)1989